Healthtech Series B Investors & VC Firms
1216 firms in this list, with a median first check of $750K. 285 of them lead rounds. Generated from verified public data and updated continuously.
Business Growth Fund
LondonSeed–Growth$3.8M – $38M
9 people
GR Capital
LondonSeries A–Growth$3.2M – $10.8M
6 people
Nueterra Capital
LeawoodSeed–Late Stage
6 people
ORI Capital
Hong KongPre-Seed–Late Stage
15 people
Texas Ventures
HoustonSeed–Late Stage
6 people
Think.Health
BerlinSeed–Growth$550K – $11M
3 people
MRL Ventures Fund
CambridgePre-Seed–Series B$25M
5 people
ISA Ventures
Cedar RapidsPre-Seed–Late Stage$25K – $1M
1 person
Elysian Park Ventures
Los AngelesSeed–Growth$500K – $100M
10 people
JStar Capital Investments
AustinSeed–Late Stage
13 people
AgeTech Capital
TorontoPre-Seed–Growth
15 people
Logos
San FranciscoSeries A–Series B
15 people
Global BioAccess Fund
New YorkSeries A–Late Stage$10M
11 people
Switch Ventures
San FranciscoPre-Seed–Series B
8 people
Founders Future
ParisPre-Seed–Growth
15 people
RBCx
TorontoSeries A–Series B
9 people
Viola Credit
LondonPre-Seed–Late Stage$2M – $50M
12 people
Catalyst Health Ventures
BostonSeed–Series C$1M – $3M
8 people
coparion
CologneSeed–Series B$540K – $8.6M
11 people
Parceiro Ventures
MinneapolisSeed–Series B$100K – $5M
8 people
Terra Venture Partners
JerusalemSeed–Series B$300K – $2M
11 people
Fundamentum
GurugramSeries B–Series C$10M – $25M
4 people
Idacapital
IstanbulPre-Seed–Series B$100K – $3M
7 people
Shepherd Ventures
San DiegoSeries A–Late Stage$750K – $3M
6 people
Related lists
Series B Investors & VC Firms (4094)Healthtech Investors & VC Firms (3208)Healthtech Seed Investors & VC Firms (2488)Healthtech Series A Investors & VC Firms (2210)Series B Investors & VC Firms in United States (1625)Healthtech Investors & VC Firms in United States (1616)Healthtech Pre-Seed Investors & VC Firms (1328)SaaS Series B Investors & VC Firms (1317)Series B Investors & VC Firms in Global (1265)Enterprise Software Series B Investors & VC Firms (1242)
Data sourced from public filings and firms' own websites — see our methodology.








































































